20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Certara Inc (CERT) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in Radnor, United States with about 1,515 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, CERT reported $419M in revenue and ($2M) in net income.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Interactive charts & full statements → Open the CERT valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $408M | $419M | $385M | $354M | $336M | $286M | $244M | $209M | $164M |
| Gross Profit | $238M | $258M | $231M | $213M | $203M | $174M | $143M | $129M | $93M |
| Gross Margin % | 58.3% | 61.5% | 59.9% | 60.2% | 60.5% | 61.0% | 58.6% | 61.7% | 56.6% |
| Operating Income (EBIT) | $8M | $21M | ($2M) | ($41M) | $33M | $14M | ($24M) | $20M | ($5M) |
| Operating Margin % | 1.9% | 5.0% | -0.4% | -11.5% | 9.7% | 4.8% | -10.0% | 9.4% | -2.8% |
| Net Income | ($68M) | ($2M) | ($12M) | ($55M) | $15M | ($13M) | ($49M) | ($9M) | ($33M) |
| Net Margin % | -16.8% | -0.4% | -3.1% | -15.6% | 4.4% | -4.6% | -20.3% | -4.3% | -20.3% |
| EBITDA | $83M | $84M | $72M | $24M | $89M | $59M | $18M | $60M | $32M |
| Earnings Per Share (EPS) | $-0.44 | $-0.01 | $-0.08 | $-0.35 | $0.09 | $-0.09 | $-0.32 | $-0.06 | $-0.25 |
| Shares Outstanding (M) | 154M | 160M | 160M | 159M | 159M | 150M | 153M | 157M | 132M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $93M | $107M | $104M | $105M | $105M | $106M | $100M | $95M |
| Gross Profit | $58M | $51M | $64M | $65M | $64M | $64M | $62M | $58M |
| Gross Margin % | 62.3% | 47.4% | 62.2% | 62.0% | 61.1% | 60.8% | 61.9% | 60.8% |
| Operating Income (EBIT) | $0M | $4M | $1M | $3M | $10M | $8M | $6M | $3M |
| Operating Margin % | -0.2% | 3.7% | 0.8% | 2.9% | 9.1% | 7.2% | 6.0% | 2.7% |
| Net Income | ($55M) | ($9M) | ($6M) | $2M | ($2M) | $5M | $7M | ($1M) |
| Net Margin % | -59.3% | -8.2% | -5.7% | 1.5% | -1.9% | 4.5% | 6.6% | -1.5% |
| EBITDA | $12M | $16M | $32M | $23M | $30M | $28M | $25M | ($6M) |
| Earnings Per Share (EPS) | $-0.36 | $-0.06 | $-0.04 | $0.01 | $-0.01 | $0.03 | $0.04 | $-0.01 |
| Shares Outstanding (M) | 154M | 158M | 160M | 161M | 161M | 161M | 161M | 161M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $83M | $96M | $80M | $83M | $93M | $60M | $45M | $38M | $12M |
| Capital Expenditures (CapEx) | $21M | $27M | $21M | $15M | $13M | $9M | $8M | $10M | $11M |
| Free Cash Flow (FCF) | $62M | $70M | $59M | $67M | $80M | $51M | $37M | $29M | $0M |
| FCF Margin % | 15.1% | 16.7% | 15.4% | 19.0% | 23.8% | 18.0% | 15.1% | 13.7% | 0.1% |
| Dividends Paid | — | — | — | — | — | $0M | $20M | $1M | $75M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $10M | $12M | $29M | $32M | $18M | $17M | $49M | $17M |
| Capital Expenditures (CapEx) | $1M | $7M | $7M | $7M | $7M | $6M | $6M | $6M |
| Free Cash Flow (FCF) | $9M | $5M | $22M | $26M | $11M | $12M | $44M | $11M |
| FCF Margin % | 10.1% | 4.6% | 21.0% | 24.4% | 10.4% | 10.9% | 43.4% | 12.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.6B | $1.6B | $1.6B | $1.6B | $1.5B | $1.3B | $1.0B | $1.1B |
| Cash & Cash Equivalents | $184M | $189M | $179M | $235M | $237M | $186M | $271M | $29M | $12M |
| Total Liabilities | $433M | $494M | $516M | $516M | $493M | $470M | $447M | $545M | $559M |
| Total Debt (Short + Long-Term) | $292M | $293M | $301M | $296M | $298M | $300M | $299M | $401M | $408M |
| Total Shareholders' Equity | $967M | $1.1B | $1.1B | $1.0B | $1.1B | $1.0B | $822M | $492M | $493M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CERT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms